Login
Sign up

[ARS] GRI Bio, Inc. SEC Filing

Filing Impact

(No impact)

Filing Sentiment

(Neutral)

Form Type

ARS

07/11/2025 - 04:20 PM

ARS - GRI Bio, Inc.

ARS Filing - GRI Bio, Inc.

This filing is available as a PDF document.

Filing Type: ARS

Company: GRI Bio, Inc. (GRI)

Acceptance Date: 2025-07-11T16:20:46.000Z

View PDF Document

Source: View Original Filing on SEC EDGAR

GRI Bio

NASDAQ:GRI

GRI Rankings

#6631 Ranked by Market Cap

N/A Ranked by Dividends

GRI Latest News

Sep 11, 2025

GRI Bio Reports 6-Week Interim Lung Function Data in Ongoing Phase 2a Study in Idiopathic Pulmonary Fibrosis (“IPF”)

Sep 3, 2025

GRI Bio to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Aug 14, 2025

GRI Bio to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech

Jul 31, 2025

GRI Bio CEO, Marc Hertz, Participates in Virtual Investor “What This Means” Segment

Jul 31, 2025

GRI Bio Reports 6-Week Interim Biomarker Data in Ongoing Phase 2a Study in Idiopathic Pulmonary Fibrosis (“IPF”)

GRI Latest SEC Filings

Nov 14, 2025

[424B3] GRI Bio, Inc. Prospectus Filed Pursuant to Rule 424(b)(3)

Nov 14, 2025

[10-Q] GRI Bio, Inc. Quarterly Earnings Report

Sep 22, 2025

[Form 4] GRI Bio, Inc. Insider Trading Activity

Sep 22, 2025

[Form 4] GRI Bio, Inc. Insider Trading Activity

Sep 22, 2025

[Form 4] GRI Bio, Inc. Insider Trading Activity

GRI Stock Data

Market Cap 4.25M

Float 2.51M

Insiders Ownership 0.02%

Institutions Ownership 0.78%

Short Percent 2.01%

Industry Biotechnology

Sector Pharmaceutical Preparations

Website Link

Country United States

City LA JOLLA